Associate Professor Pilar Blancafort
University of Western Australia
$449,356
2022 - 2024
The Research
Currently, there is no test to identify which women with ER+ breast cancer will have a positive treatment response to hormone therapy, and which women are likely to be at greater risk of relapse.
Dr Blancafort and her team have discovered a gene that is prolific in aggressive forms of breast cancer.
In this project, Dr Blancafort and her team will use breast cancer samples to develop a test to detect this gene. The team will also investigate how the gene is able to reprogram cancer cells, with the aim of identifying drugs capable of blocking this mechanism and turning off its ability to encourage cancer growth.
share
.svg)
